Key result
During a low-sodium diet, aldosterone concentrations were higher in HIV-infected than non-HIV-infected subjects and increased with visceral adiposity.
Why the study?
Is RAAS activation associated with visceral adiposity and insulin resistance in HIV-infected patients?
Cross-Sectional (n=30)
Is RAAS activation associated with visceral adiposity and insulin resistance in HIV-infected patients?
Excess RAAS activation is associated with visceral adiposity in HIV-infected patients and may independently contribute to insulin resistance, suggesting a potential therapeutic role for mineralocorticoid blockade.
Answers are grounded in this paper and cite their sources.
Aldosterone elevation with visceral adiposity in HIV may contribute to insulin resistance; hypothesis-generating and should not yet change practice.
CONTEXT: Little is known about renin-angiotensin-aldosterone system (RAAS) activation in relationship to visceral adipose tissue (VAT) accumulation in HIV-infected patients, a population at significant risk for insulin resistance and other metabolic disease. DESIGN: Twenty HIV and 10 non-HIV-infected subjects consumed a standardized low sodium or liberal sodium diet to stimulate or suppress the RAAS, respectively. RAAS parameters were evaluated in response to each diet and a graded angiotensin II infusion. Further analyses were performed after groups were substratified by median VAT measured by magnetic resonance imaging. RESULTS: Aldosterone concentrations during the low-sodium diet were higher in HIV than non-HIV-infected subjects [13.8 (9.7, 30.9) vs 9.2 (7.6, 13.6) ng/dL, P = .03] and increased across groups stratified by visceral adipose tissue (VAT) [8.5 (7.1, 12.8), 9.2 (8.1, 21.5), 11.4 (9.4, 13.8), and 27.2 (13.0, 36.9) ng/dL in non-HIV-infected without increased VAT, non-HIV-infected with increased VAT, HIV-infected without increased VAT, HIV-infected with increased VAT, respectively, overall trend P = .02]. Under this condition, plasma renin activity [3.50 (2.58, 4.65) vs 1.45 (0.58, 2.33) ng/mL · h, P = .002] was higher among the HIV-infected subjects with vs without increased VAT. Differences in the suppressibility of plasma renin activity by graded angiotensin infusion were seen stratifying by VAT among the HIV-infected group (P < .02 at each dose). In addition, aldosterone (P = .007) was an independent predictor of insulin resistance in multivariate modeling, controlling for VAT and adiponectin. CONCLUSION: These data suggest excess RAAS activation in relationship to visceral adiposity in HIV-infected patients that may independently contribute to insulin resistance. Mineralocorticoid blockade may have therapeutic potential to reduce metabolic complications in HIV-infected patients with increased visceral adiposity.
No takes yet. Share an insight, caveat, or question.
Srinivasa et al. (2015) conducted a cross-sectional in HIV infection, visceral adiposity, and insulin resistance (n=30). HIV infection and visceral adiposity vs. Non-HIV-infected subjects was evaluated on Aldosterone concentrations during the low-sodium diet (p=0.03). During a low-sodium diet, aldosterone concentrations were higher in HIV-infected than non-HIV-infected subjects and increased with visceral adiposity.
Synapse has enriched 10 related papers. Consider them for comparative context: